Edwin Albert D'Souza, Paulo Roberto Villa, Chang Chiann, Guilherme Keichi Nakandakare, Rafael Costa, David Queiroz Borges Muniz, Guilherme Filaho de Freitas, Vivian Naomi Horita, João Carlos Resende Martins, Leopoldo Alves Ribeiro-Filho, Caio Suartz, Wilson Calvo, Elaine Bortoleti de Araujo, William Carlos Nahas, Jose Mauricio Mota. "Polypharmacy and potential drug–drug interactions with novel androgen receptor signaling inhibitors (ARSIs) in patients (pts) with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC) in a real-world setting.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.346